RxSight Inc (NAS:RXST)
$ 34.5 -1.1 (-3.09%) Market Cap: 1.39 Bil Enterprise Value: 1.16 Bil PE Ratio: 0 PB Ratio: 5.01 GF Score: 59/100

Q3 2024 Rxsight Inc Earnings Call Transcript

Nov 07, 2024 / 09:30PM GMT
Release Date Price: $50.85 (-7.09%)
Operator

Thank you for standing by. My name is Andrea and I will be your conference operator today. At this time, I would like to welcome everyone to the Rx I third quarter, 2024 earnings conference call. All lines have been placed in mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again, I would now like to turn the call over to Oliver Moravcevic, Vice President of Investor Relations. Thank you. Please go ahead.

Oliver Moravcevic
Rxsight Inc - Vice President, Investor Relations

Thank you operator presenting today are Rxsight President and Chief Executive Officer, Dr Ron Kurtz and Chief Financial Officer Shelley Tuan. Earlier today, Rite released financial results for the three months ended. September 30, 2024. A copy of the press release is available on the company's website before we begin. I would like to inform you that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot